…
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Agilon Health operates a technology-enabled platform that partners with independent physician groups to manage care for Medicare Advantage beneficiaries. Long-term growth drivers include aging demographics and rising Medicare Advantage enrollment, expansion of physician partnerships, and scaling of care-management capabilities. Investors may find it attractive because the model generates recurring fee revenues from multi-year contracts and could benefit from cost savings and quality-linked incentives.
Key investment risks include exposure to Medicare reimbursement and policy changes, concentration of revenue in partner physician groups and regions, execution risk in scaling operations, and uncertainty around profitability and cash flow tied to population health performance.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -404.10M | -248.83M | -194.46M | -105.69M | -404.60M |
| Minority interest | 0.00M | -0.05M | 0.24M | -0.31M | -0.30M |
| Net income | -405.35M | -260.15M | -262.60M | -106.86M | -405.48M |
| Selling general administrative | 238.54M | 268.91M | 285.76M | 218.94M | 455.82M |
| Selling and marketing expenses | - | - | 0.19M | - | - |
| Gross profit | -188.61M | 4.84M | 69.67M | 112.29M | 76.41M |
| Reconciled depreciation | 28.59M | 24.46M | 18.92M | 13.77M | 14.67M |
| Ebit | -397.45M | -242.65M | -187.80M | -110.21M | -393.95M |
| Ebitda | -368.86M | -218.19M | -167.64M | -96.44M | -383.78M |
| Depreciation and amortization | 28.59M | 24.46M | 20.16M | 13.77M | 10.17M |
| Non operating income net other | - | - | - | 24.73M | -4.50M |
| Operating income | -421.08M | -292.13M | -232.13M | -110.21M | -393.95M |
| Other operating expenses | 6353.65M | 6352.66M | 4548.50M | 218.94M | 2227.51M |
| Interest expense | 6.64M | 6.18M | 6.66M | 4.53M | 6.15M |
| Tax provision | 1.25M | 1.45M | 1.10M | 1.64M | 0.89M |
| Interest income | 8.48M | 8.81M | 9.83M | 4.53M | 6.15M |
| Net interest income | -6.64M | -6.18M | -6.48M | -4.53M | -6.15M |
| Extraordinary items | 14.00M | -9.82M | -67.55M | 0.47M | -1.30M |
| Income tax expense | 1.25M | 1.45M | 0.79M | 1.18M | 0.89M |
| Total revenue | 5932.58M | 6060.53M | 4316.36M | 2708.21M | 1833.56M |
| Total operating expenses | 232.46M | 296.97M | 301.80M | 218.94M | 470.37M |
| Cost of revenue | 6121.19M | 6055.69M | 4246.69M | 2595.93M | 1757.15M |
| Total other income expense net | 16.98M | 43.30M | 37.67M | 4.53M | -10.65M |
| Discontinued operations | - | - | - | 0.47M | -1.30M |
| Net income from continuing ops | -405.35M | -250.28M | -88.83M | -107.33M | -405.48M |
| Net income applicable to common shares | -391.35M | -260.15M | -262.60M | -106.55M | -406.49M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1271.29M | 1733.98M | 1740.87M | 1697.47M | 1586.25M |
| Intangible assets | 65.72M | 72.77M | 63.77M | 67.68M | 55.40M |
| Other current assets | 137.76M | 35.14M | 49.27M | 34.12M | 33.75M |
| Total liab | 1144.56M | 1263.03M | 1079.85M | 656.86M | 494.66M |
| Total stockholder equity | 126.73M | 470.95M | 661.84M | 1041.22M | 1091.90M |
| Other current liab | 1057.25M | -2.46M | 968.06M | 346.73M | 351.96M |
| Common stock | 4.15M | 4.12M | 4.06M | 4.12M | 4.00M |
| Capital stock | 4.15M | 4.12M | 4.06M | 4.12M | 4.00M |
| Retained earnings | -1978.32M | -1586.98M | -1326.83M | -1064.23M | -957.68M |
| Other liab | - | - | - | 73.40M | 188.59M |
| Good will | 0.00M | 24.13M | 24.13M | 41.54M | 41.54M |
| Other assets | 20.12M | 80.60M | 0.00M | 86.54M | 225.92M |
| Cash | 173.71M | 193.86M | 107.57M | 497.07M | 1040.04M |
| Cash and equivalents | 173.71M | 188.23M | - | 497.07M | 1040.04M |
| Total current liabilities | 1076.48M | 1152.01M | 977.16M | 535.09M | 356.96M |
| Current deferred revenue | - | - | -970.91M | -346.73M | -351.96M |
| Net debt | -136.90M | -149.90M | -55.26M | -453.59M | -991.64M |
| Short term debt | 19.24M | 2.46M | 9.10M | 5.00M | 5.00M |
| Short long term debt | 19.24M | - | 6.25M | 5.00M | 5.00M |
| Short long term debt total | 36.81M | 43.96M | 52.31M | 43.48M | 48.40M |
| Other stockholder equity | 2099.99M | 2053.89M | 1986.90M | 2106.89M | 2045.57M |
| Property plant equipment | 28.96M | 36.95M | - | 20.05M | 9.16M |
| Total current assets | 1096.70M | 1457.77M | 1480.08M | 1451.27M | 1367.19M |
| Long term investments | 59.79M | 61.76M | 44.75M | 17.35M | 6.69M |
| Net tangible assets | - | - | - | 932.00M | 994.96M |
| Short term investments | 111.43M | 211.74M | 380.77M | 411.90M | - |
| Net receivables | 673.79M | 1017.04M | 942.46M | 497.57M | 293.41M |
| Long term debt | 15.75M | 34.90M | 32.31M | 38.48M | 43.40M |
| Inventory | - | - | -42.51M | 10.61M | - |
| Accounts payable | 1057.25M | 1149.55M | 968.06M | 530.09M | 351.96M |
| Noncontrolling interest in consolidated entity | - | - | - | -0.61M | -0.30M |
| Accumulated other comprehensive income | 0.92M | -0.09M | -2.30M | -5.56M | - |
| Common stock total equity | - | - | - | 4.12M | 4.00M |
| Retained earnings total equity | - | - | - | -1064.23M | -957.68M |
| Non currrent assets other | 23.66M | 80.60M | 87.15M | 116.92M | 112.96M |
| Non current assets total | 174.59M | 276.21M | 260.79M | 246.19M | 219.06M |
| Capital lease obligations | 1.83M | 6.60M | 10.90M | 9.88M | 7.90M |
| Long term debt total | 15.75M | 34.90M | - | 38.48M | 43.40M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 133.72M | 139.89M | -49.79M | -412.23M | -75.74M |
| Change to liabilities | - | - | - | 53.84M | 17.66M |
| Total cashflows from investing activities | 88.61M | 139.89M | -44.02M | -444.39M | -90.51M |
| Net borrowings | 0.00M | -3.75M | -5.00M | -5.00M | -34.64M |
| Total cash from financing activities | -2.99M | -2.58M | -193.13M | 28.06M | 1154.39M |
| Change to operating activities | - | - | - | 79.00M | 149.31M |
| Net income | -391.35M | -260.10M | -262.80M | -106.86M | -406.79M |
| Change in cash | -20.15M | 79.53M | -393.35M | -547.14M | 915.73M |
| Begin period cash flow | 193.86M | 114.33M | 507.68M | 1054.82M | 139.09M |
| End period cash flow | 173.71M | 193.86M | 114.33M | 507.68M | 1054.82M |
| Total cash from operating activities | -105.76M | -57.78M | -156.20M | -130.81M | -148.16M |
| Issuance of capital stock | - | 1.17M | 13.84M | 33.06M | 1170.94M |
| Depreciation | 28.59M | 24.46M | 20.16M | 13.77M | 14.67M |
| Other cashflows from investing activities | -31.87M | -41.77M | -34.51M | -16.73M | -8.21M |
| Dividends paid | - | - | 6.87M | - | - |
| Change to account receivables | 344.58M | -74.58M | -460.37M | -204.17M | -298.08M |
| Sale purchase of stock | -2.99M | 1.17M | -200.00M | 33.06M | 1189.03M |
| Other cashflows from financing activities | -2.99M | -3.75M | -44.02M | -444.39M | 103.35M |
| Change to netincome | - | - | - | 20.63M | 300.33M |
| Capital expenditures | 13.24M | 13.25M | 30.82M | 32.66M | 13.43M |
| Change receivables | - | - | - | -204.17M | -149.04M |
| Cash flows other operating | - | - | - | 91.97M | 75.00M |
| Cash and cash equivalents changes | - | - | - | -547.14M | 915.73M |
| Change in working capital | 189.47M | 130.59M | -10.07M | -59.44M | -55.02M |
| Stock based compensation | 49.12M | 50.66M | 69.33M | 28.38M | 292.39M |
| Other non cash items | 18.40M | -3.38M | 27.18M | -7.19M | 9.82M |
| Free cash flow | -119.00M | -71.03M | -187.01M | -163.47M | -161.59M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AGL agilon health Inc |
-0.07 0.06% |
113.32 | - | 178.57 | 0.26 | 6.82 | 0.24 | -104.52 |
| HCA HCA Healthcare, Inc. |
9.74 1.97% |
504.73 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
10.62 3.75% |
293.95 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.27 1.86% |
14.79 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
0.29 5.59% |
5.57 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
440 Polaris Parkway, Westerville, OH, United States, 43082
562 256 3800
856
| Name | Title | Year Born |
|---|---|---|
| Mr. Steven Jackson Sell | Pres, CEO & Director | 1966 |
| Mr. Timothy S. Bensley | Chief Financial Officer | 1960 |
| Mr. Girish Venkatachaliah | Chief Technology Officer | 1974 |
| Mr. Ben Shaker | Chief Markets Officer | 1983 |
| Mr. Veeral Desai | Chief Strategy & Devel. Officer | 1981 |
| Ms. Priscilla Kasenchak | Chief Accounting Officer | 1981 |
| Mr. Matthew Dale Gillmor CFA | VP of Investor Relations | NA |
| Ms. Denise Zamore | Chief Legal Officer & Sec. | NA |
| Ms. Claire Mulhearn | Chief Communications & Public Affairs Officer | NA |
| Mr. Mat Varghese | Chief People Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.